FindTrial
Sign In

The effectiveness of Acceptance & Commitment Therapy on cognitive emotion regulation strategies, Anxiety, Depression, Headache Disability and Headache intensity in patients with Chronic Daily Headache

The effectiveness of Acceptance & Commitment Therapy on cognitive emotion regulation strategies, Anxiety, Depression, Headache Disability and Headache intensity in patients with Chronic Daily Headache

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017091236145N1
Enrollment
40
Registered
2017-11-20
Start date
2016-12-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Daily Headache.

Interventions

Intervention 1: Intervention Group (Acceptance and Commitment Therapy): Completion of Cognitive emotion regulation Questionnaire (CERQ), Depression anxiety stress scale (DASS-21), Diary scale for head
going through 8 sessions of Acceptance and Commitment Therapy training one session a week
completion of Questionnaires after intervention. Intervention 2: Control Group (No intervention): Completion of Cognitive emotion regulation Questionnaire (CERQ), Depression anxiety stress scale (DASS
no intervention
completion of Questionnaires after intervention.
Behavior
Intervention Group (Acceptance and Commitment Therapy): Completion of Cognitive emotion regulation Questionnaire (CERQ), Depression anxiety stress scale (DASS-21), Diary scale for headache and Headach
Control Group (No intervention): Completion of Cognitive emotion regulation Questionnaire (CERQ), Depression anxiety stress scale (DASS-21), Diary scale for headache and Headache related disability in

Sponsors

Kashan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria included: having chronic daily headache according to the International Classification of Headache Disorders, 3rd edition (beta version), and tending to participate in the study exclusion criteria included: having a medical diagnosis of organic brain disorder or psychotic disorder and having a history of psychological treatments during the preceding six months.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Cognitive emotion regulation strategies. Timepoint: pretreatment and posttreatment. Method of measurement: cognitive emotion regulation strategies (CERQ).;Depression and anxiety. Timepoint: pretreatment and posttreatment. Method of measurement: DASS-21 scale.;Headache disability. Timepoint: pretreatment and 2 months after treatment. Method of measurement: headache disability inventory (HDI).;Headache intensity. Timepoint: pretreatment and 2 months after treatment. Method of measurement: diary scale of headache.—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr zanjani

Kashan university of medical science

z_zanjani2005@yahoo.com research@kaums.ac.ir+98 31 5554 0021

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026